Pre-order Enquiry
Request Free Sample
Global Gene Fragment Market Research Report 2023
SKU ID : QYR-23590213 | Publishing Date : 21-Apr-2023
Request Sample
Request Customization
Check Discounts
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
The global Gene Fragment market was valued at US$ 263.8 million in 2022 and is anticipated to reach US$ 566.5 million by 2029, witnessing a CAGR of 11.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment.
The Gene Fragment market size, estimations, and forecasts are provided in terms of sales volume (Million bp) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Fragment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Fragment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Segment by Type
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Fragment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Gene Fragment market was valued at US$ 263.8 million in 2022 and is anticipated to reach US$ 566.5 million by 2029, witnessing a CAGR of 11.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment.
The Gene Fragment market size, estimations, and forecasts are provided in terms of sales volume (Million bp) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Fragment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Fragment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Segment by Type
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Fragment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
